Importantly, in the context of SMA, about 50% CHP1 reduction was beneficial, whereas in case of ataxia, CHP1 levels were dramatically reduced, causing impaired NHE1 maturation and imbalance of pH homeostasis (Liu et al., 2013; Janzen et al., 2018). Here, SLC9A1 is linked to Ataxia.